Ventures
One engine. Many ways to push human life forward.
199 Biotechnologies is vertically integrated. Six parts, one flow — from molecule to patient. The spin-outs below began as internal needs: tools to make good science and better care move faster.
The 199 Engine
Discovery → Delivery- 01 / Drug Discovery
Engineered Yamanaka-factor reprogramming, tested first in glioblastoma models before aging
199bio.com→ - 02 / Manufacturing
GMP manufacturing of Procyanidin C1 (PCC1) and related senolytic candidates — London & Shenzhen
199labs.com→ - 03 / Diagnostics
Biological age quantification and multi-omic diagnostics
agequant.com→ - 04 / Clinical
Longevity medical concierge — prevention programmes, peptide protocols, and complex-case therapeutic protocols
199.clinic→ - 05 / Clinical Tech
Healtrix
Clinical assessment platform powering the longevity practice
- 06 / Gene Therapy
Triple Helix
Gene-therapy vector delivery and expression control
Spin-outs
Internal needs, now publicPaperFoot AI
AI for BiologyAI built specifically for biological data — genomics, proteomics, clinical signals. The research accelerant behind the 199 pipeline.
Petus AI
Pet LongevityExtending the longevity mission to companion animals — AI health coaching with licensed vet consultations
Habb
InfrastructureSelf-hosted AI agent infrastructure — a single Rust binary. Built because we needed reliable autonomous systems for our own operations.
Imprest
Agent GovernanceSpend governance for autonomous AI agents — policies, budgets, audit trails. Born from managing internal agent workflows.